Stryker spine device granted transitional pass-through payment for 2021

Alan Condon -   Print  |

SpineJack, an implantable fracture reduction system, has qualified for CMS' transitional pass-through payment as part of the 2021 Medicare Hospital Outpatient Prospective Payment System.

TPT status provides additional payments for new devices that show a substantial clinical improvement over existing technologies.

Beginning Jan. 1, the TPT payment will provide outpatient facilities with incremental Medicare payment for SpineJack for up to three years.

In September, CMS awarded SpineJack with the new technology add-on payment, which provides additional payment in the hospital inpatient setting.

"Due to the SpineJack System receiving both NTAP and TPT payment, physicians and administrators no longer have to make a decision between care and cost," Greg Siller, vice president and general manager of Stryker's interventional spine business, said in a Dec. 4 news release.

"The CMS TPT payment determination is a monumental step in providing a superior device technology in the treatment of osteoporotic vertebral compression fractures."

SpineJack is the 11th device to receive TPT status since 2016.

More articles on devices:
HCA launches AR spine surgery program at 2nd, 3rd Florida hospitals
2 CEOs on orthopedic consolidation — Don't grow for the sake of growth alone
175+ spine, orthopedic surgeons on the move in 2020

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers